Conolidine’s analgesic effects stem from its conversation with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors while in the central anxious program, conolidine modulates alternate molecular targets. A Science Advancements analyze uncovered that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, whi